Tivic Health Systems (NASDAQ:TIVC) Posts Quarterly Earnings Results

Tivic Health Systems (NASDAQ:TIVC) posted its quarterly earnings results on Monday. The company reported ($1.03) EPS for the quarter, topping analysts’ consensus estimates of ($408.00) by $406.97, FiscalAI reports. Tivic Health Systems had a negative return on equity of 202.20% and a negative net margin of 1,557.26%.

Tivic Health Systems Price Performance

NASDAQ:TIVC traded down $0.08 during trading hours on Monday, hitting $0.85. The stock had a trading volume of 20,365 shares, compared to its average volume of 232,628. The company has a 50 day simple moving average of $0.96 and a two-hundred day simple moving average of $1.81. The firm has a market capitalization of $1.50 million, a price-to-earnings ratio of -0.13 and a beta of 2.01. Tivic Health Systems has a one year low of $0.72 and a one year high of $13.23.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Tivic Health Systems in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Tivic Health Systems has an average rating of “Sell”.

Tivic Health Systems Company Profile

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.